Loading...

Alcon Inc.

ALC.SWSIX
Healthcare
Medical - Instruments & Supplies
CHF69.88
CHF-1.38(-1.94%)

Alcon Inc. (ALC.SW) Stock Overview

Explore Alcon Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 75.2/100

Key Financials

Market Cap34.6B
P/E Ratio38.74
EPS (TTM)$1.83
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Week$68.92
1 Month$69.22
3 Months$80.88
1 Year Target$88.34

ALC.SW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Alcon Inc. (ALC.SW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.89, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $88.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 38.74 and a market capitalization of 34.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

36.89RSI (14)
-0.77MACD
17.37ADX
Revenue Growth
4.82%
4.82%
Profit Growth
CHF2.26
4.52%
EPS Growth
CHF2.26
4.04%
Operating Margin
15.24%
36.00%
ROE
6.95%
4.52%
Dividend Yield
0.00%
11.75%
Analyst Recommendations data is not available for ALC.SWAnalyst Recommendations details for ALC.SW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

CEO

David J. Endicott

Employees

25,599

Headquarters

Chemin de Blandonnet 8, Geneva

Founded

2019

Frequently Asked Questions

;